The POINT BIOPHARMA brand, founded in 2018 (United States), from 588 sister brands and 17479 competing brands. POINT BIOPHARMA is a brand of ELI LILLY AND COMPANY, listed on the stock exchange of New York. POINT BIOPHARMA is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
ELI LILLY AND COMPANY
(POINT BIOPHARMA)
over 5 years*
$6,144.25